BioSpace News Archive

Tenax Therapeutics, Inc. today announced a new publication that identifies a novel mechanism of action behind the improved cardiovascular hemodynamics and exercise tolerance that was reported in the recent Phase 2 HELP Study (Burkhoff et al., JACC Heart Failure 2021; 9:360-70).

DiaCarta Inc. today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can now be commercialized within the EU and rest of the world.

Petros Pharmaceuticals, Inc. today announced that President and Chief Commercial Officer Fady Boctor is scheduled to present at the following virtual conferences: Q3 Investor Summit: August 17 – 18, 2021

Anebulo Pharmaceuticals, Inc. today announced the formation of a Scientific Advisory Board (SAB) to advise on the Company’s clinical development programs and its product pipeline.

Noxopharm Pre-clinical Study Confirms Survival Advantage of Combination LuPSMA Therapy in Prostate Cancer

Urovant Sciences, Inc. today announced the appointment of Betzy Estrada as executive vice president and chief human resources officer.

Aptevo Therapeutics Inc. today reported its financial results and business highlights for the quarter ended June 30, 2021.

Can-Fite BioPharma Ltd. today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of 5,000,000 of the Company’s American Depositary Shares

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) to ALLO-715 for the treatment of multiple myeloma.

The swabs collection kit market is expected to grow from US$ 4141.32 million in 2021 to US$ 5641.68 million by 2028; it is estimated to register a CAGR of 4.5% from 2021 to 2028.